News & Media
February 23, 2024
Andelyn Biosciences Announces New Chief Operations Officer
(COLUMBUS, Ohio) – Andelyn Biosciences announces the promotion and appointment of Cyrill Kellerhals as Chief Operations Officer (COO). Cyrill will lead...
June 22, 2023
Cell and Gene Therapy CDMO Andelyn Biosciences Celebrates Over 20 Years of Leadership and Innovation with Opening of New 180,000 Square Foot Manufacturing Headquarters
Columbus, Ohio – June 22, 2023 – Andelyn Biosciences, a pioneer in the development and manufacturing of cell and gene...
March 27, 2023
Andelyn Biosciences Announce New Chief Commercial Officer
(COLUMBUS, Ohio) – Andelyn Biosciences announces the appointment of Matt Niloff as Chief Commercial Officer (CCO). Niloff will lead the...
March 8, 2023
Inspiring the Next Generation of Women in Life Sciences
In honor of International Women's Day, EPM brings you an exclusive roundup of inspiring commentary from over 25 empowering women in the STEM and life sciences industries. These women share their personal experiences of working in these fields, the challenges they face, and their tips for encouraging young women who are wishing to pursue a career in STEM.
March 1, 2023
Andelyn Biosciences Board of Directors Announce New CEO
(COLUMBUS, Ohio) – Andelyn Biosciences Chief Operations Officer Wade Macedone has been promoted to CEO of the gene and cell...
February 1, 2023
Andelyn Biosciences and Odylia Therapeutics Partner to Manufacture Novel Gene Therapy for Vision Loss
Novel AAV Capsid Anc80 enables efficient gene transfer COLUMBUS, OH, 31st JANUARY, 2023 – Andelyn Biosciences, Inc., a pioneering and...
July 11, 2022
Optimizing Process Development Early – A critical factor in successful viral vector scale up and large scale manufacture
John Ketz and Denis Kole speak with Brandy Sargent on The Cell Culture Dish podcast about viral vector production, including current manufacturing challenges, navigating the road to commercialization, and successful scale up strategies.
February 14, 2022
Reliability and the Future of Cell & Gene Therapies
Mayo Pujols, CEO of Andelyn Biosciences, discusses how Cell & Gene companies are focusing on reliability and predictability to further advance this innovative therapy.
January 13, 2022
FDA Accepts GMP Plasmid DMF and Capacity Expansion Enabling Andelyn Biosciences to Offer Faster Gene Therapy Development
COLUMBUS, OH, January 13, 2022 – Andelyn Biosciences, a pioneering cell and gene therapy CDMO born out of Nationwide Children’s Hospital, today...
November 22, 2021
Nationwide Children’s Spinoff Andelyn Biosciences to Open New Lab in Dublin
Andelyn Biosciences has set its sights on Dublin for one of two new labs for the gene therapy company.